Inventor · disambiguated record
Scott Bidlingmaier
Also filed as: BIDLINGMAIER SCOTT · BIDLINGMAIER SCOTT M
7 granted patents·17 pending applications·49 citations·filing 1996–2025
81Inventor score
Top patents by PatentIndex Score
24 records- 0182US2024374748A1Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigenUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 0278US10533056B2Macropinocytosing human anti-CD46 antibodies and targeted cancer therapeuticsUNIV CALIFORNIA·Filed 2015·Granted Jan 14, 2020·3 cites·64 claims
- 0377US10946106B2Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigenUNIV CALIFORNIA·Filed 2016·Granted Mar 16, 2021·1 cites·11 claims
- 0477US2025333533A1Macropinocytosing human anti-cd46 antibodies and targeted cancer therapeuticsUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 0573US9145462B2Glioblastoma multiforme-reactive antibodies and methods of use thereofLIU BIN·Filed 2011·Granted Sep 29, 2015·1 cites·22 claims
- 0672US2024076399A1Engineered antibodies and uses thereofUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 0771US6642028B1Vectors and genes exhibiting increased expressionIMMUNE RESPONSE CORP INC·Filed 1998·Granted Nov 4, 2003·32 cites·17 claims
- 0870US12325755B2Macropinocytosing human anti-CD46 antibodies and targeted cancer therapeuticsUNIV CALIFORNIA·Filed 2019·Granted Jun 10, 2025·0 cites·43 claims
- 0969US2021236650A1Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigenUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 1062US2024254219A1Novel wnt agonist antibodies and therapeutic uses thereofUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1160US11702480B2Engineered antibodies and uses thereofUNIV CALIFORNIA·Filed 2017·Granted Jul 18, 2023·0 cites·17 claims
- 1259US2025145733A1Tumor-specific bispecific immune cell engagerUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1358US2025339570A1Radioimmunoconjugates and therapeutic uses thereofUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 1458US2024425601A1Compositions and methods for treating and preventing disease associated with avb8 integrinUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1557US2024101699A1Modulation of cd46 cell surface expression and therapeutic use thereofUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1657US2024307550A1Modulation of cd46 cell surface marker in both androgen receptor-positive and negative cancer cellsUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1754US5744326AUse of viral CIS-acting post-transcriptional regulatory sequences to increase expression of intronless genes containing near-consensus splice sitesIMMUNE RESPONSE CORP INC·Filed 1996·Granted Apr 28, 1998·12 cites·15 claims
- 1854US2025002587A1Prevention of posterior capsular opacification (pco) with integrin avb8 blocking antibodyUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1951US2016096883A1Glioblastoma multiforme-reactive antibodies and methods of use thereofUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
- 2048US2003224508A1Novel vectors and genes exhibiting increased expressionFiled 2003·Application pending·0 cites
- 2148US2022411508A1Compositions and methods for making and using multispecific antibodiesUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 2247US2022089752A1Compositions and methods for modulating cellular internalizationUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 2346US2021100838A1Human antibodies that bind and are internalized by mesothelioma and other cancer cellsUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 2443US2005182242A1Global analysis of protein activities using proteome chipsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Scott Bidlingmaier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →